Talia A Shmool1, Laura K Martin2, Richard P Matthews1, Jason P Hallett1. 1. Department of Chemical Engineering, Imperial College London, South Kensington Campus, London SW7 2AZ, U.K. 2. Department of Engineering Science, University of Oxford, Parks Road, Oxford OX1 3PJ, U.K.
Abstract
Novel drug candidates are continuously being developed to combat the most life-threatening diseases; however, many promising protein therapeutics are dropped from the pipeline. During biological and industrial processes, protein therapeutics are exposed to various stresses such as fluctuations in temperature, solvent pH, and ionic strength. These can lead to enhanced protein aggregation propensity, one of the greatest challenges in drug development. Recently, ionic liquids (ILs), in particular, biocompatible choline chloride ([Cho]Cl)-based ILs, have been used to hinder stress-induced protein conformational changes. Herein, we develop an IL-based strategy to predict protein aggregation propensity and thermodynamic stability. We examine three key variables influencing protein misfolding: pH, ionic strength, and temperature. Using dynamic light scattering, zeta potential, and variable temperature circular dichroism measurements, we systematically evaluate the structural, thermal, and thermodynamic stability of fresh immunoglobin G4 (IgG4) antibody in water and 10, 30, and 50 wt % [Cho]Cl. Additionally, we conduct molecular dynamics simulations to examine IgG4 aggregation propensity in each system and the relative favorability of different [Cho]Cl-IgG4 packing interactions. We re-evaluate each system following 365 days of storage at 4 °C and demonstrate how to predict the thermodynamic properties and protein aggregation propensity over extended storage, even under stress conditions. We find that increasing [Cho]Cl concentration reduced IgG4 aggregation propensity both fresh and following 365 days of storage and demonstrate the potential of using our predictive IL-based strategy and formulations to radically increase protein stability and storage.
Novel drug candidates are continuously being developed to combat the most life-threatening diseases; however, many promising protein therapeutics are dropped from the pipeline. During biological and industrial processes, protein therapeutics are exposed to various stresses such as fluctuations in temperature, solvent pH, and ionic strength. These can lead to enhanced protein aggregation propensity, one of the greatest challenges in drug development. Recently, ionic liquids (ILs), in particular, biocompatible choline chloride ([Cho]Cl)-based ILs, have been used to hinder stress-induced protein conformational changes. Herein, we develop an IL-based strategy to predict protein aggregation propensity and thermodynamic stability. We examine three key variables influencing protein misfolding: pH, ionic strength, and temperature. Using dynamic light scattering, zeta potential, and variable temperature circular dichroism measurements, we systematically evaluate the structural, thermal, and thermodynamic stability of fresh immunoglobin G4 (IgG4) antibody in water and 10, 30, and 50 wt % [Cho]Cl. Additionally, we conduct molecular dynamics simulations to examine IgG4 aggregation propensity in each system and the relative favorability of different [Cho]Cl-IgG4 packing interactions. We re-evaluate each system following 365 days of storage at 4 °C and demonstrate how to predict the thermodynamic properties and protein aggregation propensity over extended storage, even under stress conditions. We find that increasing [Cho]Cl concentration reduced IgG4 aggregation propensity both fresh and following 365 days of storage and demonstrate the potential of using our predictive IL-based strategy and formulations to radically increase protein stability and storage.
A staggering figure of over 96% of drugs
fail during development.[1] The abandoned
therapeutics, long development
timelines, and high costs incurred are major roadblocks impacting
industry and patients.[1,2] Currently, monoclonal antibodies
dominate the pharmaceutical sector, offering promising treatment options
for life-threatening diseases.[2] However,
antibodies are inherently prone to form aggregates in solution and
thus are typically stored under −20 °C to prolong shelf
life.[3] To evaluate and predict therapeutic
shelf life and determine the candidates of reduced aggregation propensity
that should advance to clinical trials, phenomenological and extensive
empirical experimental screening is conducted.[1,4,5] However, existing approaches are of high
cost, time consuming, and challenging in terms of accuracy.[5−8] Thus, novel strategies for predicting protein aggregation propensity
and identifying stabilizing solutions in formulation development are
required.Major factors shown to affect protein aggregation
behavior in solution
include temperature, pH, salt concentrations, solution ionic strength,
and exposure of solvent-accessible regions in the protein.[9,10] Generally, shifting the pH toward the isoelectric point and raising
solution ionic strength can disturb the electrostatic interactions
between the protein surfaces and the solvent and protein, required
for protein hydration.[4,8,11,12] Additionally, solubility is reduced as attractive
intermolecular forces are increased, leading to precipitation and
enhanced aggregation propensity.[3,8,12] Furthermore, even slight temperature fluctuations can result in
protein aggregation, particularly over long term-storage.[2,4,5,8] Thus,
when developing a protein therapeutic formulation, to enhance solubility
while preventing aggregation, as a first stage, solution pH is adjusted
and solutions with minimal salt concentration and low ionic strength
are typically used.[2,3,13]Recently, we developed an energy-guided experimental methodology
to determine the thermodynamic properties and enhance the conformational
stability of biomolecules using ionic liquids (ILs).[14,15] ILs are composed entirely of ions, exist in the liquid state below
100 °C, and are of high chemical tunability.[16−18] Uniquely, ILs
can be tactically used to enhance the structural and thermal stability
of diverse proteins.[14−18] While the molecular mechanisms remain largely mysterious, enhanced
thermodynamic stability of the native protein state in IL systems
has been rationalized in terms of hydrophobic confinement, specific
ion effects, and the Hofmeister series.[15,18,19] We have shown an increase in the structural and thermal
stability of therapeutics in ILs, attributed to protein sequestration,
energetically favorable from both an entropic and enthalpic perspective.[14,15] Notably, the formation of thermally and structurally stable protein
structures, following synthesis, is a thermodynamically controlled
process.[19] We consider that by determining
the thermodynamic properties, including the transition enthalpies,
entropies, and free energies, for a given protein therapeutic in IL,
it will be possible to assess and predict the aggregation propensity
and thermal and structural stability of the therapeutic. Moreover,
we can provide key insight into the molecular mechanisms of protein
aggregation suppression by ILs. Potentially, by harnessing the unique
properties of ILs, we can extend the shelf-life of pharmaceuticals
and revive lost therapeutic candidates.Herein, we mimic industrial
storage conditions and conduct a systematic
study to develop an IL-based strategy for predicting thermodynamic
stability and protein aggregation as well as product shelf life. We
select immunoglobin G4 (IgG4) of inherently high aggregation propensity[3] as our model protein and choline chloride ([Cho]Cl)
as our IL-based solvent system. [Cho]Cl was chosen as it is biocompatible,
of low molecular weight, with high solubility in water, and can be
easily synthesized with high purity and low cost.[16,20] Additionally, [Cho]Cl is a simple organic compound, ideal for the
development of a novel robust predictive approach for biotherapeutics.
Previously, we found that the optimal proportions of 10, 30, and 50
wt % of [Cho]-based ILs significantly enhanced the conformational
stability of native and modified proteins in water.[15] In light of these findings, we prepare a series of formulations
including IgG4 in 10, 30, and 50 wt % [Cho]Cl and IgG4 in water control.
While we account for the dilution factor of injectable therapeutics,
our formulations contain [Cho]Cl at relatively higher proportions
compared to the concentrations of excipient salts in therapeutic formulation.[13] Nonetheless, traditional salts, such as sodium
chloride, at similar concentrations to the [Cho]Cl content used herein,
have also been shown to enhance the solubility and structural stability
of globular proteins and injectable drug formulations.[21,22] In the absence of traditional protective agents, we investigate
the effects of pH, ionic strength, and temperature on IgG4 structural
and thermal stability and aggregation propensity, as fluctuations
in these conditions during industrial and biological processes can
enhance aggregation behavior.[3,4,8] We perform pH measurements and monitor IgG4 surface charge using
zeta potential measurements and conduct dynamic light scattering (DLS)
measurements to examine the effect of pH and ionic strength on IgG4
aggregation propensity. We acknowledge that it would be more straightforward
to individually examine the influence of pH on protein surface charge
and that of varying ionic strength on aggregation propensity; however,
singular factors are not isolated in biological, extracellular environments.
Thus, we purposefully combine and naturally tune the pH and ionic
strength and systematically examine the united influence of these
factors on IgG4 surface charge and aggregation propensity. As such,
we create realistic scenarios, triggering protein misfolding, to provide
information and develop a strategy that can be more readily translated
to preselection and optimization of pharmaceutical candidates. Furthermore,
to develop an improved accelerated stability testing approach, we
conduct temperature variable circular dichroism (CD) experiments to
investigate temperature-induced conformational changes and the folding
pathways of IgG4 in each system. We perform molecular dynamics (MD)
simulations at both 25 and 97 °C, aiming to connect our experimental
observations and gain further insight into IgG4 dynamics and aggregation
propensity in each system. Based on our initial findings of the structural,
thermal, and thermodynamic stability of IgG4 in each system, we predict
the aggregation propensity and thermodynamic properties of each IgG4
formulation following 365 days of storage under 4 °C. To test
the validity of our initial predictions, we reassess each system by
all measurements following storage. It is worth noting that while
several studies have examined the storage stability of globular proteins
and enzymes in IL,[23−25] to our knowledge, no study to date has examined the
stability of antibodies in choline-based ILs over such an extensive
period.
Results
Aggregation Propensity of Fresh IgG4 in Water and [Cho]Cl Solutions
of Varying pH and Ionic Strength
By pH measurements, we found
that by increasing [Cho]Cl concentration, with no buffer adjustment,
we could naturally lower the pH from 6.35 in water to 5.86, 5.73,
and 5.47 in 10, 30, and 50 wt % [Cho]Cl, respectively, and increase
ionic strength (0.760, 2.15, and 3.58 M for 10, 30, and 50 wt %, respectively)
(Table S1). In agreement with the literature,
we found that the mean surface charge increased with rising ionic
strength.[26,27] Specifically, we observed an increase from
6.2 ± 0.6 to 9.5 ± 0.9 mV for 10–50 wt %, respectively,
lowest for IgG4 in water (2.3 ± 0.8 mV). This is also consistent
with previous work showing that protein surface charge increases in
solutions of higher ionic strength and lower pH.[28−32]Notably, the rise in ionic strength and lower
pH of the 50 wt % [Cho]Cl environment can increase protein surface
charge and promote misfolding and precipitation.[17,29,30] However, our DLS measurements showed that
in 50 wt % [Cho]Cl, the mean hydrodynamic diameter (Dh) of fresh IgG4 was the lowest (135 ± 4 nm) and
the highest for water (410 ± 10 nm), closest to physiological
pH (Table S1). We also observed a relatively
lower PDI for all [Cho]Cl solutions compared to water. It should be
noted that our findings are in agreement with previous work in that
greater aggregation propensity should be observed close to the isoelectric
point of the protein,[5,10,27,28] in this case, IgG4 in water. Overall, these
results highlight the inherently high aggregation propensity of fresh
IgG4, lowered with [Cho]Cl addition.We predicted that if the
behavior of IgG4 is strongly controlled
by [Cho]Cl, following 365 days of storage under 4 °C, we would
observe the same rank order of reduced aggregation propensity and
increase in zeta potential values with greater [Cho]Cl concentration.
Accordingly, we also predicted minimal pH fluctuation for all [Cho]Cl
solutions. These predictions relied on the assumption that IgG4 aggregation
is hindered by [Cho]Cl addition and the ions of [Cho]Cl form low molecular
weight liquids that remain stable over extended storage.
Validating Initial Predictions of IgG4 Physical Properties and
Aggregation Propensity
Following 365 days of storage at 4
°C, pH, DLS and zeta potential measurements confirmed our initial
predictions (observations overlayed for emphasis in Figure A, B). For IgG4 stored in [Cho]Cl,
the pH of each solution only slightly decreased following storage
(5.79, 5.65, and 5.05 for stored 10, 30, and 50 wt % [Cho]Cl, respectively),
reflecting the integrity of the [Cho]Cl solutions and ability to maintain
the appropriate pH over long-term storage. As we observed for the
fresh samples (Figure C), the mean zeta potential values for the stored samples increased
with rising ionic strength (from 4.5 ± 0.7 to 8.5 ± 1.1
mV for 10–50 wt %, respectively) and decreasing pH (Figure B,D). It is worth
noting that upon addition of salt, native aggregation can increase,[4,8,30−34] yet we found the smallest increase in Dh for stored 50 wt % [Cho]Cl (159 ± 1 nm) followed
by 30 and 10 wt % (274 ± 8 and 460 ± 20 nm, respectively)
and greatest for water (649 ± 8 nm). Thus, our findings demonstrate
that by using a higher [Cho]Cl concentration, intrinsic IgG4 aggregation
propensity can be decreased and sustained over long-term storage.
We highlight that the consistency in trends following extended storage
provides the first piece of evidence that upon exposing an antibody
to an IL-based solvent, it is possible to identify, control, and predict
the long-term physical properties and stability of aggregate-prone
protein systems.
Figure 1
IgG4 in water (blue), 10 wt % [Cho]Cl (red), 30 wt % [Cho]Cl
(purple),
and 50 wt % [Cho]Cl (gray) with light and dark shades showing fresh
and stored samples, respectively. (A) Mean hydrodynamic diameter (Dh); (B) pH versus mean zeta potential for fresh
and stored samples ± SD (n = 3). Ionic strength
versus mean surface charge (solid circles) and hydrodynamic diameter
(unfilled circles) for (C) fresh and (D) stored samples ± SD
(n = 3). See the Supporting Information for values
(Table S1) and significance tests.
IgG4 in water (blue), 10 wt % [Cho]Cl (red), 30 wt % [Cho]Cl
(purple),
and 50 wt % [Cho]Cl (gray) with light and dark shades showing fresh
and stored samples, respectively. (A) Mean hydrodynamic diameter (Dh); (B) pH versus mean zeta potential for fresh
and stored samples ± SD (n = 3). Ionic strength
versus mean surface charge (solid circles) and hydrodynamic diameter
(unfilled circles) for (C) fresh and (D) stored samples ± SD
(n = 3). See the Supporting Information for values
(Table S1) and significance tests.
Ranking Fresh IgG4 Systems by Structural Stability and Identifying
the Lowest Energy State
We develop our predictive IL-based
strategy and examine heat induced protein aggregation using temperature
variable CD experiments. Figure A shows that in all cases, fresh IgG4 exhibited a negative
band at approximately 218 nm attributed to the β-sheet secondary
structure.[14] In water, IgG4 gave a much
deeper initial minimum at 218 nm (−12,800 deg cm2 dmol–1), with all [Cho]Cl samples showing similar
spectra at 25 °C (between −2800 and −3200 deg cm2 dmol–1). As the temperature was raised,
this minimum at 218 nm initially increased in depth and breadth for
all samples. Notably, compared to the [Cho]Cl systems, fresh IgG4
in water showed a relatively small change in the mean residue ellipticity
(MRE) with temperature due to the very deep initial value. In all
cases, the absolute change in MRE was between −3000 to −4500
deg cm2 dmol–1 (Table S2). As Figure A provides a qualitative picture for the structural changes and aggregation
behavior of each fresh sample, the MRE data was further analyzed at
218 nm to monitor the relative fractional change in the β-sheet
content (fβ – sheet content) (Figure B, Table S3). For each fresh system, we observed
two distinct sigmoidal regions corresponding to the thermally induced
conformational transitions and IgG4 conformational changes.[14,15] Additionally, we observed that IgG4 in water deviated from Gaussian
behavior above 85 °C, showing multiple conformational transitions
and lower thermal and structural stability compared to all [Cho]Cl
systems (Figure S1). Notably, relative
to water, we observed that both the initiation and maximum of the
peak in fβ – sheet content occurred at higher temperatures for the [Cho]Cl systems. This demonstrates
the rise in conformational, structural, and thermal stability of fresh
IgG4 with increasing [Cho]Cl concentration, similar for 30 and 50
wt % and lower for 10 wt % and water.
Figure 2
(A) MRE plots for fresh IgG4 in water
and 10, 30, and 50 wt % [Cho]Cl.
(B) ff and (C) Gibbs free energy (with temperature for fresh water
(blue circles), 10 wt % (red diamonds), 30 wt % (purple squares),
and 50 wt % [Cho]Cl (gray triangles). Dotted lines show Gaussian curves
fitted to each fresh sample data set.
(A) MRE plots for fresh IgG4 in water
and 10, 30, and 50 wt % [Cho]Cl.
(B) ff and (C) Gibbs free energy (with temperature for fresh water
(blue circles), 10 wt % (red diamonds), 30 wt % (purple squares),
and 50 wt % [Cho]Cl (gray triangles). Dotted lines show Gaussian curves
fitted to each fresh sample data set.Based on our previous work, choline-based ILs can
yield well-formed
IgG4 secondary structures and structural motifs that are energetically
favorable, directing the positioning of the secondary structural elements
of IgG4 in space.[14,15,34] To investigate this in detail, we traced the change in Gibbs free
energy for fresh samples (ΔGf) with
temperature. We found that for fresh IgG4 in water, the initial decline
began at 57 °C, decreasing to a minimum at 71 °C and then
increasing beyond this to 95 °C (Figure C). We also observed that fresh water deviated
from Gaussian behavior above 85 °C, alike the fβ – sheet content, and yielded
a higher RSS value for the obtained fit compared to the fresh [Cho]Cl
systems (Tables S4 and S5). Similar to Figure B, we found that
the negative peak in the plot of ΔGf began and reached its minimum value at higher temperatures for the
[Cho]Cl samples compared to water. Specifically, for all fresh [Cho]Cl
samples, ΔGf can be described by
a stable period at low and moderate temperatures (from 25 °C
to at least 55 °C), followed by a decrease to a minimum then
increase to at least the initial value at 97 °C. In fresh 10
wt %, the negative peak in ΔGf began
at 63 °C, with a minimum reached at 72 °C, while in fresh
30 and 50 wt % [Cho]Cl, the decrease began at 59 and 61 °C, respectively,
and both reached a minimum at 76 °C. This demonstrates the increase
in the thermodynamic stability of fresh IgG4 at higher [Cho]Cl concentrations
and the temperature dependence of ΔG and the fβ – sheet content for each fresh sample.To further investigate the systems
most likely to improve thermodynamic
stability, we calculated ΔGmin,
as the minimum value on the Gaussian fit of the raw data. ΔGmin corresponds to the temperature at which
the conformational states show the greatest fβ – sheet content. We found that
for the fresh [Cho]Cl samples, ΔGf became more negative with increasing [Cho]Cl content
(from −3.3 ± 0.4 kJ/mol at 10 wt % to −7 ±
1 kJ/mol at 30 wt % to −8.3 ± 0.9 kJ/mol for 50 wt %),
showing greater thermodynamic stability.[14,15] In water, ΔGf was
also more negative (−8 ± 1 kJ/mol), but the observed deviation
from the Gaussian model at higher temperatures indicated that IgG4
in water is highly aggregation-prone, more so with increasing temperature.
Notably, fresh IgG4 in [Cho]Cl systems did not show such deviation
from the Gaussian model.Based on the results for the fresh
samples, we expected that following
365 days at 4 °C, IgG4 stored in water and 10 wt % [Cho]Cl would
exhibit greater structural changes than 30 and 50 wt %. Given that
fresh water showed a deviation from the Gaussian model at higher temperatures,
we predicted that stored water would also show this above 80 °C.
Moreover, since fresh 10 wt % showed the least negative ΔGf, we also anticipated a distortion
from the Gaussian model at higher temperatures for stored IgG4 in
10 wt %. Finally, we expected that compared to ΔGf, for stored water and 10 wt %, ΔGs would become more negative and
change more in magnitude compared to stored 30 and 50 wt % [Cho]Cl.
These predictions would hold true if in water and 10 wt % IgG4 aggregation
propensity increases over storage, and thus, the ΔGs values become more negative to compensate
and enhance IgG4 thermodynamic stability.[35−38] Notably, our predictions are
made in the framework that the fitted ΔG curve
essentially demonstrates the force of folding, and ΔGf can be used to predict ΔGs and the stored final IgG4 conformations.
Verifying Predictions and Examining the Final Stored IgG4 Structures
Following 365 days at 4 °C, all stored samples showed a loss
in secondary structure beyond the temperature at which the negative
band reached its maximum amplitude (Figure A). This was most pronounced for stored water.
We observed a small difference in secondary structure loss for the
stored [Cho]Cl samples, in line with our initial projection. Specifically,
the well at 218 nm became deeper for all stored samples except for
50 wt % [Cho]Cl, which retained almost an identical initial well depth
of −3000 deg cm2 dmol–1 after
storage, compared to −3200 deg cm2 dmol–1 fresh (Table S2). Furthermore, the increase
in well depth with heating was also raised for all stored samples
except 50 wt %, indicating a lower loss in secondary structure and
reduced IgG4 aggregation propensity with [Cho]Cl addition.
Figure 3
(A) MRE plots
following 365 days at 4 °C for stored IgG4 in
water and 10, 30, and 50 wt % [Cho]Cl. (B) fs and
(C) ΔG with temperature for stored water (dark
blue circles), 10 wt % (dark red diamonds), 30 wt % (dark purple squares),
and 50 wt % (dark gray triangles). Dotted lines show Gaussian curves
fitted to each stored sample data set.
(A) MRE plots
following 365 days at 4 °C for stored IgG4 in
water and 10, 30, and 50 wt % [Cho]Cl. (B) fs and
(C) ΔG with temperature for stored water (dark
blue circles), 10 wt % (dark red diamonds), 30 wt % (dark purple squares),
and 50 wt % (dark gray triangles). Dotted lines show Gaussian curves
fitted to each stored sample data set.Consistently, each stored sample displayed a Gaussian
curve for
the fs with temperature (Figure B). The peak in fs in water occurred at the lowest temperature, while the stored
[Cho]Cl samples exhibited peaks in similar positions. We also found
a third sigmoidal region between 79 and 97 °C for stored water
and between 81 and 97 °C for stored 10 wt %, satisfying our prediction
of deviation from the Gaussian model at higher temperatures for both
systems. This indicates greater structural changes for water and 10
wt % compared to 30 and 50 wt % [Cho]Cl. While for each case a different
conformational landscape is sampled by IgG4 and β-sheet-rich
conformations emerged, no distinct transition above 70 °C was
visible for stored IgG4 in 30 and 50 wt %, in line with our prediction
of reduced aggregation propensity with increasing [Cho]Cl concentrations.Overall, for all stored samples, the curve shape for ΔGs with temperature (Figure C) showed minimal differences to that of
ΔGf and could be fitted to a Gaussian
model. As temperature was raised, ΔGs decreased to a minimum, ΔGs, and subsequently increased to greater than its initial value.
In the stored [Cho]Cl samples, the ΔGs well started at nearly the same temperature as in the fresh samples
(65, 61, and 59 °C for 10, 30, and 50 wt %, respectively); and
ΔGs also occurred
at very similar temperatures (72, 76, and 73 °C for 10, 30, and
50 wt % [Cho]Cl, respectively). After storage in water, ΔGs decreased by 11 °C, with
the negative peak in ΔGs initiating
at a much lower temperature than stored [Cho]Cl samples and fresh
water, starting at just 45 °C, reaching the minimum at 60 °C
and returning to initial values by 71 °C before increasing further.
Notably, as predicted, we observed more negative values for ΔGs for all stored samples compared
to fresh ΔGf. Specifically,
both stored water (−11 ± 1 kJ/mol) and 10 wt % (−4.6
± 0.4 kJ/mol) showed the greatest percentage changes (37 and
40% compared to ΔGf, respectively), whereas ΔGs for stored 30 wt % (−7.9 ± 0.6 kJ/mol) and 50
wt % (−9.5 ± 0.9 kJ/mol) showed smaller relative changes
(9 and 14% compared to ΔGf, respectively). This further supports the claim that in higher
[Cho]Cl concentrations, the thermodynamic stability of IgG4 is greater
and aggregation propensity is reduced.[14,15,37,38]To highlight
the predictive power of our IL-based strategy, using
the initially determined trends and calculated thermodynamics of fresh
IgG4 systems to determine the behavior of stored systems, we overlayed
ΔGf and ΔGs, ΔGf and ff, andΔGs and fs (Figures and S2). Evidently, for fresh and stored IgG4 in
water (Figure A, B
and C, respectively) and the equivalent three plots for fresh and
stored IgG4 in 50 wt % [Cho]Cl (Figure D, E and F, respectively), we can clearly observe the
distortion from the Gaussian model above 81 °C for water, also
found above 83 °C for 10 wt % (Figure S1). We can see this is absent for 50 and 30 wt % (Figure S2), which gave a Gaussian distribution across the
entire temperature range examined. Overall, our findings indicate
that stored IgG4 in 50 wt % exhibits the highest thermodynamic stability,
followed by 30 wt %, lowest for 10 wt % [Cho]Cl and water, as predicted.
Figure 4
For IgG4
in water, overlays of (A) ΔGf and
ΔGs, (B) ΔGf and ff, and (C) ΔGs and fs. For IgG4 in 50 wt % [Cho]Cl, overlays of (D) ΔGf and ΔGs,
(E) ΔGf and ff,
and (F) ΔGs and fs. Circles and diamonds represent the behavior of freshly prepared
and stored samples, respectively, with dotted and dashed lines showing
the Gaussian curves fitted to the data sets and used to calculate
ΔGmin. Solid symbols (left axis)
and unfilled symbols (right axis) show ΔGmin and fβ – sheet content, respectively. For all samples, see Figure S2.
For IgG4
in water, overlays of (A) ΔGf and
ΔGs, (B) ΔGf and ff, and (C) ΔGs and fs. For IgG4 in 50 wt % [Cho]Cl, overlays of (D) ΔGf and ΔGs,
(E) ΔGf and ff,
and (F) ΔGs and fs. Circles and diamonds represent the behavior of freshly prepared
and stored samples, respectively, with dotted and dashed lines showing
the Gaussian curves fitted to the data sets and used to calculate
ΔGmin. Solid symbols (left axis)
and unfilled symbols (right axis) show ΔGmin and fβ – sheet content, respectively. For all samples, see Figure S2.
Determining and Validating Predictions of IgG4 Aggregation Propensity
and Thermodynamic Properties
By additional thermodynamic
calculations of each system, we further develop our strategy for predicting
the thermodynamic properties and protein aggregation in solution over
365 days of storage at 4 °C. Initially, we found that the first
melting transition of fresh IgG4 (Tf) in water (63.2 ± 0.8 °C) was lower than that for
fresh [Cho]Cl solutions (69.8 ± 0.2, 67.8 ± 0.2, and 69.2
± 0.1 °C for 10, 30, and 50 wt %, respectively) (Table ). This indicated
that in the absence of [Cho]Cl, IgG4 adopts conformations of lower
thermal stability. In the fresh [Cho]Cl samples, higher concentrations
served to reduce the initial change in entropy (ΔSf) (1370 ± 70 J/K/mol for 10 wt %, 1090
± 50 J/K/mol for 30 wt %, and 1080 ± 20 J/K/mol for 50 wt
%) and change in enthalpy (ΔHf) (96 ± 5 kJ/mol for 10 wt %, 74 ± 3 kJ/mol for 30
wt %, and 75 ± 1 kJ/mol for 50 wt %). However, both ΔHf and ΔSf, associated with the second sigmoidal transition
of the fresh samples, were raised with increasing [Cho]Cl concentrations
(84 ± 5 kJ/mol and 1110 ± 60 J/K/mol, 108 ± 7 kJ/mol
and 1280 ± 90 J/K/mol, and 137 ± 5 kJ/mol and 1650 ±
60 J/K/mol for 10, 30, and 50 wt % [Cho]Cl, respectively). Notably,
the relatively higher ΔH and ΔS values for [Cho]Cl systems compared to solely water is
logical, as the addition of [Cho]Cl molecules would lead to some structural
rearrangement.[14,15] Additionally, we observed that Tf, associated with the second sigmoidal
transition of fresh samples, was comparable for water (77.7 ±
0.3 °C) and 10 wt % (76.6 ± 0.4 °C), yet raised for
30 wt % (84.3 ± 0.2 °C) and 50 wt % (82.9 ± 0.1 °C),
indicating greater thermal stability of IgG4 in higher [Cho]Cl concentrations.
Table 1
fβ – sheet content, Melting Temperature (Tm), Enthalpy
(ΔH), and Entropy (ΔS) for Each Sigmoidal Region of Fresh and Stored Samples of IgG4 in
Water and Solutions of 10, 30, and 50 wt % [Cho]Cl, Heated from 25
to 95 °C. Determined from CD Data, As Described Previously[14]
sample
Tm1 (°C)
ΔH1 (kJ/mol)
ΔS1 (J/K/ mol)
Tm2 (°C)
ΔH2 (kJ/ mol)
ΔS2 (J/K/mol)
Tm3 (°C)
ΔH3 (kJ/mol)
ΔS3 (J/K/mol)
water
63.2 ± 0.8
34 ± 2
530 ± 40
77.7 ± 0.3
100 ± 10
1300 ± 100
water stored
52.8 ± 0.8
43 ± 4
810 ± 80
67.2 ± 0.2
62 ± 3
920 ± 50
85.8 ± 0.5
50 ± 10
600 ± 100
10%
69.8 ± 0.2
96 ± 5
1370
± 70
76.6 ±
0.4
84 ± 5
1110 ± 60
10%
stored
69.5 ± 0.1
120 ± 3
1720 ± 50
75.8 ± 0.3
120 ± 10
1600 ± 200
92.2 ± 0.4
100 ± 20
1100 ± 200
30%
67.8 ± 0.1
74 ± 3
1090
± 50
84.3 ±
0.2
108 ± 7
1280 ± 90
30%
stored
68.2 ±
0.1
81 ± 1
1180 ± 20
83.0 ± 0.1
145 ± 5
1740 ± 60
50%
69.2 ± 0.1
75 ± 1
1080 ± 20
82.9 ± 0.1
137 ± 5
1650 ± 60
50% stored
66.1 ± 0.1
75 ± 1
1130 ± 20
80.4 ± 0.2
96 ± 5
1200 ± 70
Following 365 days of storage under 4 °C, all
[Cho]Cl systems
showed negligible changes in Ts and Ts (Table ), yet for water we
observe a significant decrease in both values (Ts = 52.8 ± 0.8 °C and Ts = 67.2 ± 0.2 °C). This emphasizes
the reduced thermal stability as compared with [Cho]Cl solutions.
Additionally, ΔHs increased
in all cases following storage, except for 50 wt % (75 ± 1 kJ/mol)
that remained unchanged, and the value of ΔSs showed smaller increases for 30 and 50 wt
% (1180 ± 20 and 1130 ± 20 J/K/mol) compared to 10 wt %
and water (810 ± 80 and 1720 ± 50 J/K/mol). Additionally,
we observed a reduction in ΔHs and ΔSs for
stored 50 wt % (96 ± 5 kJ/mol and 1200 ± 70 J/K/mol), yet
an increase for 10 and 30 wt % (120 ± 10 kJ/mol and 1600 ±
200 J/K/mol for 10 wt % and 145 ± 5 kJ/mol and 1740 ± 60
J/K/mol for 30 wt %). Moreover, we found the expected third sigmoidal
transition of stored water and 10 wt % with ΔHs and ΔSs (50 ± 10 kJ/mol and 600 ± 100 J/K/mol for
water and 100 ± 20 kJ/mol and 1100 ± 200 J/K/mol for 10
wt %). Overall, these findings further demonstrate the enhanced thermal,
structural, and thermodynamic stability of IgG4 with [Cho]Cl addition.
MD Simulations for Assisting in Evaluating Predictions and Interpreting
IgG4 Dynamics
To gain further insight into our observed reduction
in aggregation propensity and increase in IgG4 mean zeta potential
at higher [Cho]Cl concentrations, we characterized IgG4 surface charge
by mapping the electrostatic surface potential (ESP) of the IgG4 crystal
structure (Figure ). This mapping was carried out on the antibody protonation state
+22 e at pH 5. It should be noted that while pH 5 is below the isoelectric
point of IgG4,[28,39,40] it was selected because the calculated protonation states of IgG4
were found to remain constant in the pH range between approximately
4.5 and 5.5.
Figure 5
Electrostatic surface potential map for the IgG4 antibody
with
identifiable Fc, Fab, and hinge regions, with positive Fv regions shown on each Fab fragment, coloring of negative (red) to
positive (blue) charge.
Electrostatic surface potential map for the IgG4 antibody
with
identifiable Fc, Fab, and hinge regions, with positive Fv regions shown on each Fab fragment, coloring of negative (red) to
positive (blue) charge.We found the majority of positive charge to be
located on the variable
region (Fv) of the Fab fragments (Fab1 and Fab2) of the
investigated IgG4. A lower number of positively charged regions were
located on the Cγ2–Cγ3 interface
of the Fc fragment, known to bind via different motifs that vary depending
on the protein interactions.[41] We also
observed that the exposed negatively charged regions on the antibody
surface are predominantly localized on the IgG4 hinge, with smaller
negatively charged regions found on the Fc and Fab fragments. On the
basis of this, it is expected that the large number of positive regions
found on the IgG4 ESP map leads to the preferential exclusion of [Cho]Cl
species in solution, and extensive electrostatic interactions and
hydrogen bonding between the [Cho]Cl molecules and IgG4 chain restrict
IgG4 aggregation at higher concentrations.[42]As we developed our predictive IL-based strategy, we carried
out
MD simulations at 25 °C, starting from the crystal structure
of Pembrolizumab (PDB ID – 5DK3)[43] solvated in water and in 10, 30, and 50 wt % [Cho]Cl of increasing
ionic strength. We also performed simulations at 97 °C to examine
the dynamics of IgG4 and correlate our findings with the experimentally
determined thermodynamic stability of IgG4 at elevated temperatures.In this work, we computed preferential interaction coefficients,
Γ23, by means of minimum distance distribution functions
(MDDFs) and the Kirkwood–Buff (KB) theory of solvation. This
approach has previously been used to examine aqueous IL-protein interactions.[14,44] Additionally, we employed the indistinguishable ion approach to
account for the cationic and anionic co-solute species in the calculation
of Γ23, whereby the preferential interaction coefficients
of the choline cation and the chloride anion were calculated separately
and then combined to provide a single Γ23 for the
co-solutes. This method has been recently shown to provide reasonable
results for ionic excipients[45] and ILs.[46]From our simulations at 25 °C, we
found that the Γ23 values decreased with increasing
[Cho]Cl concentration,
from −1.0 ± 0.12 to −2.8 ± 0.18 and −3.1
± 0.15 for 10, 30, and 50 wt %, respectively. This indicated
that [Cho]Cl is preferentially excluded from the antibody surface
for each system and acts as a protectant, thus stabilizing the protein[38,39] and reducing IgG4 aggregation propensity, most significantly at
50 wt %, in agreement with our experimental results. These findings
are consistent with previous work showing the protectant effect of
[Cho][DHP] on cytochrome C,[47] ribonuclease
A,[25] and human serum albumin,[48] resulting in enhanced stabilization of these
systems.Next, we examined the minimum distance distribution
functions (MDDFs),
providing insight into the individual ion-IgG4 interactions and details
of the probability of finding the choline and chloride ions relative
to the antibody surface (Figure S3). We
found that for each [Cho]Cl system examined, overall, the choline
cations preferentially interact with the antibody surface as opposed
to the chloride anions. However, while at low concentrations the weakly
hydrated chloride anions are distributed throughout the solution,
the occurrence of chloride anions interacting with the IgG4 surface
increases with [Cho]Cl concentration. This is indicated by the absence
of a distinct short-range peak, typically observed in the MDDFs. Specifically,
from hydrogen bonding analysis, we determined that the choline cations
can act as both hydrogen bond donors and acceptors. For example, we
found that the hydroxyl groups of the choline cations form hydrogen
bonds with the oxygen atoms of the asparagine groups, including ASN141,
ASN214, ASN533, and ASN876, on IgG4. Additionally, amino groups on
the indole ring of the tryptophan groups, prominently TRP814, TRP990,
and TRP1041, on IgG4 formed hydrogen bonds with the oxygen atoms of
the choline cations. We also found that the choline cations interact
via hydrogen bonds with the cystine amino acids, such as CYX218, on
the IgG4 hinge region. Furthermore, our results are in line with previous
studies of specific ion effects on protein-IL interactions in aqueous
ILs,[49−51] which have found that large organic cations preferentially
interact directly with the antibody surface, whereas the behavior
of the anions is highly dependent on the basicity of the anion and
the strength of the anion–water interactions.[52−56]We consider that IgG antibodies are highly flexible due to
the
composition of the hinge region, which allows for a relatively unhindered
motion of the two Fab arms in solution.[41,57,58] Accounting for this, we examined the global structure
of IgG4 in water and each [Cho]Cl solution, allowing us to assess
the effect of ionic strength on IgG4 dynamics and correlate this to
our experimental results. This was achieved by calculating the root
mean squared deviation (RMSD) (Figure S4) and assessing the Fab-Fab and Fab-Fc distances calculated between
the center-of-mass of each domain (Figure S5). Additionally, we examined the root mean squared fluctuations (RMSF)
to further understand the effect of ionic strength, varied by [Cho]Cl
concentration, on the dynamics of the individual amino acids in the
IgG4 chain.At 25 °C, RMSD values of the individual Fab
and Fc fragments
(Figure S4) revealed that the individual
IgG4 domains remained relatively stable. Moreover, we found that the
increased RMSD for the Fab1 and Fc fragments in water and 10 wt %
[Cho]Cl solutions correspond to the formation of a Fab-Fc interface.
This was confirmed by investigation of the Fab-Fab and Fab-Fc distances
(Figure S5). Notably, the change in RMSD
and corresponding formation of a Fab-Fc interface was not observed
for IgG4 in 30 and 50 wt % [Cho]Cl. From the RMSF we find that, in
general, the fluctuations of the individual amino acids are dampened
with increasing ionic strength. This is consistent with previous protein-IL
simulation studies that have shown that the addition of ILs reduces
protein dynamics.[59]We note that
the X-ray crystal structure (Figure A) presents an idealized Y-shaped conformer
of the antibody. Upon simulating in water and in 10 wt %, we found
that IgG4 transitioned to adopting a λ-shaped conformer (Figure B). For the 30 and
50 wt % [Cho]Cl solutions, we observed that a Y-shaped conformer was
preferred over the λ–shaped conformer of IgG4 (Figure C). Based on previous
MD simulations, a λ-shaped conformer has been found for the
anti-natriuretic peptide receptor A (NPRA) IgG4 antibody.[58] Accordingly, in our simulations, the λ-shaped
conformer arises via the formation of an Fc-Fab interface (predominantly
Fc–FabHL). Notably, we did not observe the equally
probable formation of the Fc–FabKM interface, possibly
due to the unique rotation of the Fc CH2 region associated
with the Pembrolizumab IgG4 which may block Fc-Fab association.
Figure 6
(A) Y-shaped
structure from the crystal structure of IgG4 (PDB
ID-5DK3);[43] (B) λ-shaped structure
found to dominate in water and 10 wt % at 25 °C; (C) Y-shaped
structure as found for the 50 wt % [Cho]Cl simulations at both 25
and 97 °C.
(A) Y-shaped
structure from the crystal structure of IgG4 (PDB
ID-5DK3);[43] (B) λ-shaped structure
found to dominate in water and 10 wt % at 25 °C; (C) Y-shaped
structure as found for the 50 wt % [Cho]Cl simulations at both 25
and 97 °C.In line with our experimental results and predictions,
by the 97
°C simulations we found a general increase in the antibody fragment
motions, particularly the Fab arms and Fc tail, in the case of water
and 10 wt % [Cho]Cl. This is indicated by the greater RMSD (Figure S6) values and the preferential formation
of a Fab-Fc interface and the λ-shaped conformer.[58] Specifically, we observed enhanced flexibility
and motion of the Fab fragments, compared to the higher concentration
[Cho]Cl solutions. Additionally, at 97 °C, we observed a greater
relative orientation and movement of one of the Fab arms and Fc tail
of the antibody in 30 wt % [Cho]Cl (Figures S6 and S7), thereby facilitating a transition
from the Y-shaped conformer to the λ-shaped conformer. Notably,
this is in contrast to our observation of the Y-shaped conformer preferred
over the λ–shaped conformer of IgG4 for 30 wt % at 25
°C. For 50 wt %, we observed a preference for the Y-shaped conformer
at both 25 and 97 °C. This indicates that the increased [Cho]Cl
concentration restricts the formation of the λ–shaped
conformer. We note that the transition from the Y-shaped conformer
to the λ-shaped conformer cannot be entirely discounted as longer
simulations may reveal this transition; however, this is unlikely
based on our thermodynamic calculations.
Discussion
In deciphering the effects of [Cho]Cl on
IgG4 aggregation propensity,
we considered that the ability of aqueous [Cho]Cl-based ILs to stabilize,
denature, or induce the aggregation of proteins is, to some extent,
comparable to conventional co-solutes, such as guanidinium chloride,
triethylamine-N-oxide, and urea.[16,52] In particular, a detailed theoretical framework for the application
of KB theory and preferential binding models have been presented for
examining the interactions between ILs and proteins, such as the interaction
of aqueous alkylimidazolium- based ILs with peptides and proteins.[44,60] Based on our experimental data, thermodynamic calculations, and
observations from the MD simulations, we suggest that the charge screening
effect of [Cho]Cl, IgG4 compaction, and the formation of a strong
network of [Cho]Cl molecules around IgG4 provide the stabilization
and reduced aggregation propensity at higher [Cho]Cl concentrations.
Specifically, we propose that the choline cations form hydrogen bonds
and hydrophobic interactions with the charged amino acids and protein
backbone, stabilizing the folded conformations of IgG4.[14] Together, the chloride anions can contribute
to enhanced structural stability against collapse by electrostatic
interactions,[14,15] forming a viscoelastic interfacial
stabilization network hindering changes in the protein structure,
adsorption at the air–water interface, and increase in dynamic
surface tension.[16,61−63] Furthermore,
the observed Y-shaped conformer adopted in 30 and 50 wt % at 25 °C
suggests dampening of the dynamics for these systems, possibly due
to preferential interactions of IgG4 with [Cho]Cl in concentrated
solutions. From this, we infer that water is excluded from the vicinity
of the protein surface, also supported by the highest Γ23 values observed for water. Accordingly, for water and 10
wt % [Cho]Cl, the formation of the Fab-Fc interface and increase in
IgG4 conformational flexibility can be explained by the unavailability
of sufficient [Cho]Cl molecules for compaction via electrostatic and
hydrogen bonding interactions at the surface, leading to the enhanced
aggregation propensity.Given that fresh 30 and 50 wt % showed
more negative ΔGf values,
we suggest that the
[Cho]Cl molecules bind to IgG4 to stabilize the initial conformation,
having cooperative folding transitions with a strong bias toward native
interactions.[14,35,64,65] As such, adding [Cho]Cl can raise the free
energy barrier of unfolding, limiting intermediate states, and thus
hindering aggregation.[14,35,37,64−66] In line with the higher
folding energy barriers promoting the transition of misfolded forms
into the folded conformations,[35,64,65] the less negative value of ΔGf for 10 wt % and the third sigmoidal region found for water
suggest that the IgG4 conformational space is explored so that high
energy regions are avoided. Consequently, the conversions between
the folded and misfolded states are more frequent,[35,37,64] explaining the greater aggregation propensity
observed for water and 10 wt %. Additionally, the relatively higher Tf and Tf for the [Cho]Cl systems compared to water corroborate
the claim that with [Cho]Cl addition, we can expect conformations
of greater thermal stability and folded states not accessible in water.
We propose that for each system, IgG4 flexibility should be finely
balanced with thermal stability. To illustrate, we observed a decrease
in ΔHf and ΔSf with increasing [Cho]Cl concentration,
reflecting that the entropic contribution to IgG4 thermal stability
is much smaller for fresh 30 and 50 wt % compared to 10 wt % [Cho]Cl,
consistent with our previous work.[14,15] This suggests
that the thermal stability is coupled to the enhanced conformational
stability of the folded state.[64−67] Following this logic, fresh IgG4 in 10 wt % [Cho]Cl
showed the highest ΔHf and ΔSf values, demonstrating
that the enhanced thermal stability of this system is a consequence
of an increase in the conformational entropy of the folded state ensembles.
Furthermore, ΔHf and
ΔSf were the lowest
for 10 wt % and comparable for fresh water and 30 wt % [Cho]Cl, with
the [Cho]Cl systems showing significantly higher amounts of secondary
structure. This indicates a tendency to adopt a more native-like folded
conformation at Tf for IgG4
in [Cho]Cl. Thus, we suggest that if stabilizing interactions are
perturbed, increasing the entropy of the folded state could lead to
stabilization, provided these exceed the loss of enthalpic contribution.[14,15,35,64]Following 365 days of storage under 4 °C, our DLS, zeta
potential,
and CD measurements demonstrated that IgG4 in water is highly prone
to aggregation and the addition of [Cho]Cl served to preserve native
residue–residue interactions over storage. This was highlighted
by the observations of greatest loss in secondary structure, largest
change in ΔGs, and
lowest Ts and Ts all in water. Based on our initial results,
for IgG4 in 50 wt %, we expected conformational changes to be suppressed
due to confinement effects.[15,35−38] In this case, we predicted that stored 50 wt %, with most native
contacts, would show an increase in ΔHs and ΔSs and decrease in ΔSs and ΔHs, relative
to the fresh systems. We found that for the [Cho]Cl systems examined,
only stored 50 wt % showed a decrease in ΔHsand ΔSs and the lowest ΔSs. This aligns with our initial predictions and proposal that
charge screening, compaction, and long-range hydrophobic contacts
at higher [Cho]Cl concentrations can restrict IgG4 aggregation.[14,15,64−67] Accordingly, for stored 30 wt
%, which showed an increase in ΔHs, ΔSs,
ΔHs, and ΔSs and a more negative ΔGs compared to 10 wt %, the enhanced
thermal and structural stability observed can be attributed to compaction
and greater solution viscosity. This is also supported by the greater
RMSD value found for water and 10 wt % [Cho]Cl at the 97 °C MD
simulations, and the preferential formation of a Fab-Fc interface
and greater motion of the Fab fragments compared to 30 and 50 wt %.
Moreover, in line with our initial predictions, we observed a third
subtle transition, Ts, for
stored 10 wt % [Cho]Cl and water, of greatest aggregation propensity.
We rationalize that conformational changes and bond formations between
the amino acid residues can increase the entropic cost, and the ability
of IgG4 to adopt multiple conformations can lead to an increase in
surface hydrophobicity and aggregation propensity.[64−67] Notably, as IgG4 in water is
expected to potentially populate a large number of conformations for
a given type of fold,[7,14,64] we can obtain conformationally stable yet misfolded β-sheet-rich
structures of low thermal stability, explaining the more negative
ΔGs of stored water.
We suggest that in higher [Cho]Cl concentrations, a small number of
conformations are consistent with forming a thermodynamically stable
antibody, and we can construct systems in which tight packing between
[Cho]Cl and the amino acid side chains leads to enhanced IgG4 thermal,
structural, and thermodynamic stabilization over extended storage.
Notably, there is a growing demand for novel pharmaceutical excipients,
with multifaceted and unique properties, to aid in suppressing aggregation
and prolonging the shelf life of protein therapeutics.[1−3,13] However, in order to circumvent
the requirements of compiling extensive supportive information and
regulatory approval, the pharmaceutical sector remains heavily reliant
on well-established and pre-approved excipients.[2,3,5] Introducing ILs into the pharmaceutical
development pipeline has immense potential for enhancing the quality
and performance of protein therapeutic candidates and opening new
avenues for formulation innovation.
Conclusions
We developed an IL-based strategy for predicting
the thermodynamic
stability and aggregation propensity of IgG4, intrinsically prone
to aggregation in solution. We examined the stresses of pH, ionic
strength, and temperature and evaluated the structural, thermal, and
thermodynamic stability and aggregation propensity of IgG4 in water
and 10, 30, and 50 wt % [Cho]Cl. We developed our predictive approach
in two stages. First, we conducted DLS, zeta potential, and variable
temperature CD experiments to systematically assess each fresh system.
Based on initial results, we predicted the aggregation propensity
and thermodynamic properties of IgG4 in each system following 365
days under 4 °C. Upon re-evaluation of each system following
extended storage, we found reduced aggregation propensity with increasing
[Cho]Cl concentration, highest for water. We propose that for the
solutions of higher ionic strength and pH levels below the isoelectric
point of IgG4, the charge screening effect and preferential binding
of the [Cho]Cl molecules to the IgG4 surfaces enable compaction and
enhanced thermodynamic stability. This is supported by our experimental
findings and thermodynamic calculations, as well as our MD simulations
showing reduction of IgG4 motion at higher [Cho]Cl concentrations.
We demonstrated that by adding [Cho]Cl, it is possible to guide conformational
sampling via [Cho]Cl-local residue interactions that bias IgG4 chain
fragments toward forming secondary structures of reduced aggregation
propensity. This likely involves favorable long-range interactions,
local packing, side chain hydrogen bonding, and burial of hydrophobic
amino acids away from water. Thus, our IL-based approach for predicting
protein aggregation propensity and thermodynamic stability can be
thought of in the framework of reversing a protein-folding problem.
Instead of searching for the lowest energy conformation for a given
protein, the goal is to determine the solution conditions that will
stabilize a desired conformation or binding interaction. Based on
the validation of our thermodynamically controlled predictions, we
achieved a high level of success. We envision that our strategy can
be applied to a wide range of [Cho]-based ILs and deep eutectic solvents
for predicting and enhancing the thermodynamic and storage stability
of diverse proteins with novel folds.
Materials and Methods
Materials and Formulation Preparation
IgG4 was produced
as previously described.[14] [Cho]Cl was
purchased from Sigma-Aldrich Company Limited (Gillingham, Dorset,
UK) and stored as recommended. Ultrapure water was used for preparing
the formulations and obtained from a PURELAB Ultra water purifier
(ELGA LabWater, High Wycombe, UK) with resistivity of 18.2 MΩ.
An aqueous stock solution of [Cho]Cl was prepared by addition of ultrapure
water to the salt, then shaking at room temperature for 1 hour to
give 80 wt % [Cho]Cl solution. From the 80 wt % solution, aqueous
stock solutions of 10, 30, and 50 wt % [Cho]Cl were prepared. Each
aqueous stock [Cho]Cl solution contained 20 mg mL–1 of IgG4, filtered using 0.22 μm syringe filter units (Thermo
Fisher Scientific Inc., Waltham, MA USA). All formulations were immediately
stored at 4 °C until measured. Prior to a measurement, a sample
was prepared from each stock IgG4-[Cho]Cl solution, with IgG4 filtered
and diluted to a concentration of 0.4 mg/mL. For the experimental
measurements performed, these conditions were previously found optimum.[14−16] For each solution, IgG4 concentration was confirmed by measurements
on the NanoDrop One ThermoFischer Scientific Inc. (Thermo Fisher Scientific
Inc., Waltham, MA USA).
pH DLS and Zeta Potential Measurements
The pH of each
solution was measured using the pH electrode Mettler Toledo InLab
Micro (WOLFLABS, Pocklington, York, UK). As previously described,[16] to investigate the change in Dh and PDI, DLS measurements were performed using a Zetasizer
Nano ZS (Malvern Panalytical Ltd., Malvern, UK) at a 90° scattering
angle; and to determine the surface charge, zeta potential measurements
were performed using the Litesizer 500 (Anton Paar GmbH, Ostfildern,
Germany). For each experiment, the average of three results is reported.
All samples were measured under identical conditions, fresh and following
365 days of storage at 4 °C.
Variable Temperature CD Spectroscopy Measurements and Analysis
To examine the structural, thermal, and thermodynamic stability
of the formulations, temperature variable CD experiments were performed
on a Chirascan CD spectrometer (Applied Photophysics Ltd., Leatherhead,
Surrey, UK) in combination with a Quantum Northwest Peltier temperature
controller (Quantum Northwest Inc., Liberty Lake, WA, USA), as previously
described.[14,15] Samples were measured with a
heating rate of 1 °C/minute between 25 and 97 °C at 2 °C
intervals between 200 and 260 nm. Samples were measured fresh and
following 365 days of storage at 4 °C. CD data was processed
and analyzed following the methodology described previously.[14]Briefly, Origin software (OriginLab Corporation,
Northampton, MA, USA) was used to zero and smooth the data. MRE was
calculated, and the data at 218 nm was converted into a plot of the
relative fraction of the β-sheet content, fβ – sheet content, of the
protein at each temperature, calculated by logistic regression as
follows:where y is
the experimentally measured CD signal, y0 is the minimum magnitude CD signal, and ymax is the strongest CD signal (maximum of the negative peak), with fβ – sheet content = 0 at y = y0 and fβ – sheet content = 1 at y = ymax.A Gaussian curve was fitted to each data set with the peak width
and area under the curve extrapolated directly from this fit. Percentage
change in the area and width between fresh and stored samples were
calculated, relative to the fresh sample, with a positive change indicating
an increase (and vice versa) (Table S3).The thermodynamics parameters of each transition were calculated
using the two-stage model, fitted to a sigmoidal curve. The fraction
of protein in the final conformation (f) was then
calculated as shown in eq , and the equilibrium constant was determined asand from there, the free energy
of the transition, ΔGm, was calculated
asfor ideal gas constant R. ΔGm was plotted linearly
against T in the transition region (−5 kJ
mol–1 < ΔGm < 5 kJ mol–1), with Tm as the midpoint of the sigmoid and the point at which exactly
half of the molecules are the initial and final ensembles and ΔGm = 0. The enthalpy (ΔHm) and entropy (ΔSm)
of each transition were estimated from the ΔGm and Tm using[14]ΔGm was also plotted against T across the entire
temperature range examined, resulting in a curve which was fitted
to an inverted Gaussian, the minimum of which was defined as ΔGmin.
MD Simulations and Analysis
The structure of the IgG4
antibody was modeled based on the crystal structure of the full length
IgG4 antibody, Pembrolizumab (resolution 3.2 Å, PDB entry: 5DK3).[43] The original crystal structure consisted of
an IgG4 dimer, from which we employed only the A (light) and B (heavy)
chains and retained the glycan chains in our simulations. Missing
residues were generated using Modeller prior to assigning protonation
states. The protonation state of the antibody was assigned at pH 5.0
using the H++ webserver.[68] This produced
an overall charge of +22 e for the antibody. To account for potential
local changes in the protonation state at the lower pH of IgG4 in
the [Cho]Cl systems, protonation states were also determined at pH
4.5 and 5.5. At these pH values, the protonation state was found to
remain at +22 e.For aqueous simulations, one IgG4 was solvated
in a cubic TIP3P water box with a minimal distance of 14 Å between
the boundaries of the box and the nearest protein atoms using the
tleap module in Ambertools18.[69] For simulations
containing [Cho]Cl, the number of [Cho]Cl and water species was calculated
to retain the same box size as the aqueous simulations while maintaining
the experimental concentrations. Table S6 shows the number of [Cho]Cl and water molecules used to simulate
IgG4 in 10, 30, and 50 wt % [Cho]Cl. Each simulation cell contained
one full antibody molecule. This generated simulation boxes containing
∼490 to 570 k atoms. The starting structures for each these
systems was generated using Packmol.[70] The
corresponding disulfide and glycan linkages and parameter and topology
files were generated using tleap.Protein residues were simulated
using the Amber ff14SB force field.[71] Amber
consistent parameters were employed for
the chloride anions,[72] while choline cations
were described using the General Amber Force Field (GAFF)[73] and RESP charges.[74] Subsequently, charges on the species were scaled to 0.8. This led
to an imbalance of charge in each system of −2 e, which was
then balanced with the addition of 2 Na+ ions.[72] This approach toward neutralizing the overall
system charge has previously been shown to have little effect on the
protein structure and dynamics.All solvated structures were
then subjected to two-stage energy
minimization. In the first stage of 5000 steps, the protein was restrained
to its crystallographic positions using a harmonic potential with
a force constant of 25 kcal/(mol Å2) while all other
atoms were unrestrained. In the second stage of 5000 steps, no restraints
were applied. In both stages, the steepest descent method was used
for the 1st 2500 steps and the conjugate gradient method was switched
on for the rest of the steps. Each system was then subjected to 500
ps of heating (NVT) and 1 ns pre-equilibration in the NPT ensemble
to obtain the required temperature and density. Three independent
150 ns simulations at 25 °C and two independent 300 ns simulations
at 97 °C were performed for each system in the NPT ensemble.
Notably, high temperature simulations were carried out to improve
the dynamics of the highly viscous systems and further examine the
validity of the IL-based predictive approach and conclusions obtained
from the experimental analysis and thermodynamic calculations. The
higher temperature of 97 °C was selected based on previous work,
which revealed that an IgG Fab fragment retains its secondary structure
in IL-water solutions at 127 °C, with no denaturation observed.[14] All simulations were carried out using Amber18,[69] employing the same settings as used in previous
work.[14] Primary analysis of each trajectory
was carried out with CPPTRAJ.[75]To
probe the role of [Cho]Cl in enhancing the stability or the
aggregation propensity of IgG4, we computed the preferential interaction
coefficients of each system. This was performed using the ComplexMixtures
(v0.4.13) software with R = 12 Å[44] and was carried out using the last 50 ns of
each of the simulations at 25 °C. In brief, the preferential
interaction coefficient, Γ23, of an antibody with
an excipient can be calculated by applying eq , where the subscripts 1, 2, and 3 refer to
water, protein, and excipient, respectively.[76,77]To account for the
ionic species, the choline cations and chloride
anions, we employed the indistinguishable ion approach, shown to be
a reasonable approximation for ILs.[46,78] In this approach,
Γ23 values are calculated separately for each species,
then combined using eq .[79]In this equation, Γ+ and Γ– refer to the preferential
interaction coefficients for the cation
and anion, respectively, and Z2 is the net charge of the
protein. We performed separate simulations constraining the Na+ ions at distances >10 Å from the protein surface.
Then,
the preferential interaction coefficients were computed, which revealed
that the inclusion of the two Na+ ions had a negligible
effect on the calculated properties.
Authors: Michaela Blech; Stefan Hörer; Alexander B Kuhn; Sebastian Kube; Hendrik Göddeke; Hans Kiefer; Yuguo Zang; Yannic Alber; Stefan M Kast; Martin Westermann; Mark D Tully; Lars V Schäfer; Patrick Garidel Journal: Biophys J Date: 2019-04-05 Impact factor: 4.033
Authors: Li Li; Sandeep Kumar; Patrick M Buck; Christopher Burns; Janelle Lavoie; Satish K Singh; Nicholas W Warne; Pilarin Nichols; Nicholas Luksha; Davin Boardman Journal: Pharm Res Date: 2014-06-07 Impact factor: 4.200
Authors: Alexandra Schindl; Matthew L Hagen; Shafaq Muzammal; Henadira A D Gunasekera; Anna K Croft Journal: Front Chem Date: 2019-05-24 Impact factor: 5.221
Authors: Talia A Shmool; Laura K Martin; Liem Bui-Le; Ignacio Moya-Ramirez; Pavlos Kotidis; Richard P Matthews; Gerhard A Venter; Cleo Kontoravdi; Karen M Polizzi; Jason P Hallett Journal: Chem Sci Date: 2021-06-22 Impact factor: 9.825